Scarica l'app Stockscreener
2.23
2.76%
0.06
Pre-mercato:
2.23
Creative Medical Technology Holdings Inc Borsa (CELZ) Ultime notizie
BZLEY Should I Buy - Intellectia AI
Creative Medical (CELZ) Reports Encouraging Pilot Study Results for Ultrasome Therapy - GuruFocus
Creative Medical (CELZ) Reports Promising Osteoarthritis Therapy Results - GuruFocus
BY Technical Analysis & Price Forecast - Intellectia AI
Creative Medical reports positive pilot study results for Ultrasome - Investing.com UK
Creative Medical reports positive pilot study results for Ultrasome By Investing.com - Investing.com Canada
Park Place Technologies Partners with Professional Athlete Genie Bouchard as 'Genie from IT” in New TV Commercial - The Manila Times
Uncertainty Around AI’s Impact on Careers Clouds Students’ College Decisions - The Manila Times
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies - marketscreener.com
Cell-free knee arthritis therapy posts 93% response in pilot study - Stock Titan
JXHLY Forecast — Price Prediction for 2026. Should I Buy JXHLY? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
NPSKY Technical Analysis & Stock Price Forecast - Intellectia AI
BHPCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Iran Hormuz Strait Crisis: Oil Market Impact & Energy Investment Strategy 2026 - Intellectia AI
NAII Technical Analysis & Price Forecast - Intellectia AI
MITT Technical Analysis & Price Forecast - Intellectia AI
RWAY Technical Analysis & Price Forecast - Intellectia AI
Creative Medical Technology Holdings, Inc. 2025 Annual Report: Executive Summary, Compensation, and Compliance Disclosures - Minichart
IBEX Technical Analysis & Price Forecast - Intellectia AI
TOVXPrice, Charts & Blockchain Insights - Intellectia AI
Creative Medical (NASDAQ: CELZ) details 2025 pay, ownership and deals - Stock Titan
VMC Technical Analysis & Price Forecast - Intellectia AI
GE Vernova Stock Analysis 2026: Q1 Earnings Beat Signals Powerhouse Momentum - Intellectia AI
HDSN Technical Analysis & Price Forecast - Intellectia AI
CreativeMed (CELZ) Volatility Analysis | Q3 2025: Profit SurprisesBest Pick - Cổng thông tin điện tử tỉnh Lào Cai
PVH Technical Analysis & Price Forecast - Intellectia AI
VIVK Technical Analysis & Price Forecast - Intellectia AI
Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN
CreativeMed (CELZ) Stock Moving VWAP (Advances) 2026-04-18Open Stock Signal Network - Newser
$ADA PE Ratio & Valuation, Is $ADA Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Breakout Zone: Can Creative Medical Technology Holdings Inc continue delivering strong returns2026 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
Growth Review: What is the earnings history of Creative Medical Technology Holdings IncQuarterly Trade Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Street Watch: Does AVPTW have a sustainable dividendPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Opening: Is Sky Harbour Group Corporation being accumulated by smart money2026 Earnings Impact & Stepwise Trade Signal Guides - baoquankhu1.vn
CREATIVE MEDICAL TECHNOLOGY HOLDINGS Operating Margin %: -64 - GuruFocus
Income Plays: Is Creative Medical Technology Holdings Inc forming bullish engulfing patternsIndex Update & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Aug Weekly: Is Starwood Property Trust Inc a top pick in the sectorLayoff News & Stepwise Trade Execution Plans - baoquankhu1.vn
New Highs: What is ACCOs market positionPortfolio Update Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long - Yahoo Finance
Leading Companies Enhancing Their Presence in the Cancer Anorexia-Cachexia Syndrome (CACS) Market - openPR.com
TKWY-NL PE Ratio & Valuation, Is TKWY-NL Overvalued - Intellectia AI
What are analysts price targets for Royal Caribbean Cruises LtdEntry Point & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Alphabet, Inc. | History, Products, & Business Segments - Britannica
KPET Ultra Paceline Corp 2026 Audited Balance Sheet and Financial Statement Highlights - Minichart
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
NXL PE Ratio & Valuation, Is NXL Overvalued - Intellectia AI
CELZ (Creative Medical Technology Holdings) Policyholder Fu - GuruFocus
When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Sahm
Clean Energy Technologies, Inc. (CETY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Recap Report: Is Creative Medical Technology Holdings Inc stock risky to hold nowQuarterly Profit Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Does CreativeMed (CELZ) Stock pay reliable income | Price at $2.22, Up 3.74%Beta Signals - Newser
Growth Review: What is Creative Medical Technology Holdings Incs 5 year growth outlook2026 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
If You Invested $1,000 in Creative Med Technology Hldgs (CELZ) - Stock Titan
Aug Rallies: What is Creative Medical Technology Holdings Incs 5 year growth outlook2026 Sector Moves & Real-Time Volume Trigger Notifications - baoquankhu1.vn
BMRA PE Ratio & Valuation, Is BMRA Overvalued - Intellectia AI
Aug Weekly: Is Creative Medical Technology Holdings Inc. a strong candidate for buy and hold2026 Setups & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Creative Medical Technologies Holdings, Inc. 2025 Annual Report: Regenerative Stem Cell Therapies, Clinical Trials, and Intellectual Property Portfolio 151926293035 - Minichart
Creative Medical (NASDAQ: CELZ) details 2025 losses and regenerative trial progress - Stock Titan
Creative Medical Technology Holdings 10-K: Revenue $0.006M, EPS $(2.52) - TradingView
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):